Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02936323
Title PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tarveda Therapeutics
Indications

adrenal medulla cancer

large cell neuroendocrine carcinoma

pancreatic endocrine carcinoma

neuroendocrine tumor

neuroendocrine carcinoma

pulmonary neuroendocrine tumor

paraganglioma

thyroid gland medullary carcinoma

gastrointestinal neuroendocrine tumor

pheochromocytoma

lung small cell carcinoma

Merkel cell carcinoma

Therapies

PEN-221

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.